How many FDA citations were issued in cities within Seminole County in Q3

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA - Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA - Official Website
0Comments

There were two companies in cities associated with Seminole County that received FDA citations as a result of two inspections conducted in the county over the third quarter of 2025, according to the U.S. Food and Drug Administration (FDA).

This is unchanged from the number of companies cited in the previous quarter.

The citations in the county include:

  • The written MDR procedure does not include an internal system which provides for a standardized review process/procedure for determining when an event meets the criteria for reporting.
  • Management with executive responsibility has not ensured that the quality policy is understood, implemented and maintained at all levels of the organization.
  • Quality audits have not been performed.

All of the companies cited were involved in the Devices sector.

Both companies cited should take voluntary actions to correct their managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Companies Located within Seminole County Cities and the Citations They Received in Q3
Company Name Area of Business Inspection Date Issue Cited
Magnatone Hearing Aid, CORP Devices 07/14/2025 Lack of System for Determining MDR Events
Magnatone Hearing Aid, CORP Devices 07/14/2025 Management ensuring quality policy is understood
Magnatone Hearing Aid, CORP Devices 07/14/2025 Quality Audit/Reaudit – conducted
Magnatone Hearing Aid, CORP Devices 07/14/2025 Change records, content
Magnatone Hearing Aid, CORP Devices 07/14/2025 Purchasing controls, Lack of or inadequate procedures
Magnatone Hearing Aid, CORP Devices 07/14/2025 Lack of or inadequate procedures
Magnatone Hearing Aid, CORP Devices 07/14/2025 Lack of or inadequate complaint procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Label to bear a unique device identifier
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Lack of Written MDR Procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Management review – Lack of or inadequate procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Quality System Procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Quality audits – Lack of or inadequate procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Training – Lack of or inadequate procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Design control – no procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Design Validation – Risk analysis not performed/inadequate
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Purchasing controls, Lack of or inadequate procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Lack of or inadequate In-process acceptance procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Nonconforming product, Lack of or inadequate procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Lack of or inadequate procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Lack of or inadequate complaint procedures
Tactical Medical Systems Thermal Management Group Devices 08/08/2025 Devices subject to device identification GUDID data submission requirements.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Sara Brenner, Principal Deputy Commissioner at FDA

How many companies in cities across Orange County received FDA citations in Q1?

There were four companies in cities associated with Orange County that received FDA citations as a result of four inspections conducted in the county over the first quarter of 2026, according to reports from the U.S. Food and Drug Administration (FDA).

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

Cities located in Orange County saw FDA inspections of 17 companies in Q1

There were 17 companies in cities associated with Orange County that received 17 FDA inspections in the first quarter of 2026, according to the U.S. Food and Drug Administration.

Bryan Nelson, Mayor at City of Apopka

Apopka Splash Pad at Kit Land Nelson Park to close for resurfacing May 18-24

The City of Apopka will temporarily close its Splash Pad at Kit Land Nelson Park from May 18-24 for resurfacing. Officials say this work aims to keep the facility safe and clean. Residents are encouraged to check online updates during the closure.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from North Orlando News.